The landscape of genetic medicine took a significant stride forward as pharmaceutical giant Eli Lilly and Company joined forces with…
Read More
Ultrathin Ruthenium Dioxide Breakthrough Reveals Altermagnetism Potential and Offers New Pathways for Next-Generation Spintronics and Computer Memory
A novel phase of quantum magnetism known as altermagnetism could fundamentally transform the architecture of modern computing, rendering digital memory…
Read More
From RAG to Agentic AI: Building the Next Generation of Intelligent Enterprise Systems
The enterprise technology landscape is undergoing a structural transformation as organizations pivot from basic Retrieval-Augmented Generation (RAG) frameworks to sophisticated…
Read More
Evogene and ELEO Forge Strategic Alliance to Pioneer Next-Generation Oral PCSK9 Inhibitors for Cardiovascular Disease
Evogene and ELEO have officially announced a significant scientific collaboration poised to accelerate the discovery and development of novel oral…
Read More
The Fusion of Light and Magnetism in Atomically Thin Semiconductors Paves the Way for Next-Generation Quantum Technologies
Researchers at the City College of New York (CCNY) have published a seminal review in the journal Nature Materials, signaling…
Read More
Rethinking the Neural Architecture of Decision Making to Inform Next Generation Artificial Intelligence
A landmark study conducted by researchers at the University of Illinois Urbana-Champaign has challenged long-standing neuroscientific paradigms regarding how the…
Read More
Boehringer Ingelheim Eyes MASH as the Next Front for Survodutide, a GLP-1/Glucagon Receptor Dual Agonist
For decades, fatty liver disease, specifically metabolic dysfunction-associated steatotic liver disease (MASLD), and its more severe inflammatory form, metabolic dysfunction-associated…
Read More
Boehringer Ingelheim eyes MASH as the next front for survodutide, a GLP-1/glucagon receptor dual agonist
For decades, metabolic dysfunction-associated steatohepatitis (MASH), a more serious inflammatory form of fatty liver disease, remained a largely overlooked condition,…
Read More
Small Language Models Are Powering Next-Generation Agents in a Paradigm Shift for AI
For the past two years, the prevailing wisdom in the burgeoning field of agentic artificial intelligence hinged on a simple…
Read More
Boehringer Ingelheim Eyes MASH as the Next Front for Survodutide, a GLP-1/Glucagon Receptor Dual Agonist
For decades, fatty liver disease, specifically its more severe inflammatory manifestation known as metabolic dysfunction-associated steatohepatitis (MASH), remained a significant…
Read More
